Tabla de contenido
Idiomas disponibles
Idiomas disponibles
Linearity (µg/dL)
1
2
Dilution
Observed
5
1
16 in 16
31.9
8 in 16
13.3
4 in 16
7.5
2 in 16
3.8
1 in 16
1.9
2
16 in 16
34.5
8 in 16
15.8
4 in 16
8.6
2 in 16
4.7
1 in 16
2.1
3
16 in 16
45.3
8 in 16
20.9
4 in 16
11.2
2 in 16
5.7
1 in 16
3.1
Recovery (µg/dL)
1
2
Solution
Observed
1
—
10.8
A
16.5
B
24.6
C
28.4
2
—
8.2
A
13.8
B
20.1
C
25.9
3
—
16.7
A
23.5
B
29.4
C
33.9
6
3
4
Expected
%O/E
—
—
16.0
83%
8.0
94%
4.0
95%
2.0
95%
—
—
17.3
91%
8.6
100%
4.3
109%
2.2
95%
—
—
22.7
92%
11.3
99%
5.7
100%
2.8
111%
3
4
Expected
%O/E
—
—
15.7
105%
21.0
117%
27.7
103%
—
—
13.2
105%
18.5
109%
25.2
103%
—
—
21.3
110%
26.6
111%
33.3
102%
IMMULITE/IMMULITE 1000 Cortisol (PILKCO-16, 2016-02-08)
Specificity
1
Compound
Aldosterone
Androstenedione
Betamethasone
Corticosterone
Cortisone
11-Deoxycorticosterone
11-Deoxycortisol
21-Deoxycortisone
Dexamethasone
DHEA-SO
4
Estriol
Estrone
Fludrocortisone
Fluticasone
17-Hydroxyprogesterone
Methotrexate
Methylprednisolone
Prednisolone
Prednisone
Pregnanediol
Progesterone
Spironolactone
Tetrahydrocortisol
Tetrahydrocortisone
Triamcinolone
4
ND: not detectable
Bilirubin
Conjugated
100
200
3
Unspiked
mg/L
mg/L
1
4.1
4.7
4.4
2
9.8
9.2
9.4
3
13.7
14.9
15.7
4
20.0
21.6
20.9
5
28.4
30.3
30.7
µg/dL
% Cross
2
3
Added
reactivity
1000
ND
10,000
ND
1000
ND
400
8.6%
400
ND
400
ND
100
ND
500
ND
400
ND
10,000
ND
100
ND
500
ND
1000
0.20%
22
ND
400
ND
100
ND
200
21%
100
23%
8.0
49%
16
5.9%
2000
ND
400
ND
1000
ND
1000
0.90%
400
ND
5000
0.022%
500
ND
1
2
Unconjugated
100
200
mg/L
mg/L
4.5
4.8
9.6
9.7
15.3
16.2
22.0
21.3
30.0
30.0
Tabla de contenido
